Five Star Equities Provides Stock Research on Array Biopharma and Sunesis Pharmaceuticals
Continue ReadingTag: research-reports
High Dividend Paying Companies Losing Luster Among Investors as Dividend Tax Rate Set to Increase
Five Star Equities Provides Stock Research on Frontier Communications and Windstream
Continue Reading
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Alexza Pharmaceuticals and EntreMed
Continue Reading
Chinese Equities Receive a Boost as Manufacturing in China Rises for the First Time in 13 Months
The Paragon Report Provides Stock Research on Cleantech Solutions International and Zhongpin
Continue Reading
Consumer Spending Could Drop by as Much as $200 Billion if Upcoming “Fiscal Cliff” Is Not Avoided
The Paragon Report Provides Stock Research on The Coca-Cola and Mondelez International
Continue Reading
China to Provide Subsidies to Rare Earth Producers in Attempts to Boost Struggling Industry
Five Star Equities Provides Stock Research on Lynas and Quest Rare Minerals
Continue Reading
Demand for Rare Earths Expected to Top 200,000 Tons by 2020 — Molycorp Shares Surge as Executives Purchase Shares
Five Star Equities Provides Stock Research on Molycorp and Rare Element Resources
Continue Reading
Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
Five Star Equities Provides Stock Research on Cytokinetics and Galectin Therapeutics
Continue Reading
U.S. Foreign Oil Imports Projected to Decline by More Than 50% Within the Next Decade
The Paragon Report Provides Stock Research on Forest Oil and Petroquest Energy
Continue Reading
FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011
Five Star Equities Provides Stock Research on CytRx and ZIOPHARM Oncology
Continue Reading